Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Advanced Ovarian Cancer
NCT02001272Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2013
- Primary completion
- Feb 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 6
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in ovarian cancer, sponsored by Hospices Civils de Lyon. Started Dec 2013; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02001272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001272.